Clinical Trials Logo

Moderate to Severe Acne Vulgaris clinical trials

View clinical trials related to Moderate to Severe Acne Vulgaris.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04163263 Completed - Clinical trials for Moderate to Severe Acne Vulgaris

Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of Repeat Topical Application of BOS-356 in Subjects With Moderate to Severe Acne Vulgaris

Start date: November 4, 2019
Phase: Phase 1
Study type: Interventional

This study is being conducted to characterize the safety and tolerability of BOS-356 in adult participants with moderate to severe acne vulgaris following 14 days or 28 days of repeated topical application